Names & News

Posted: February 2017 Ugo Pastorino received the Joseph W. Cullen/Early Detection Award, which is given to to a lung cancer specialist in recognition of his or her scientific achievements in research on the prevention of thoracic malignancies. Dr. Pastorino is Director, Thoracic Surgery Division, Istituto Nazionale Tumori, Milan, Italy; and Faculty Member, School of Specialization in…

Posted: February 2017 Keunchil Park received the 2016 IASLC Merit Award, which is given to lung cancer specialists who have made extraordinary contributions to the IASLC’s development. Dr. Park is Professor, Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine in Seoul, South Korea.

Posted: February 2017 Dr. Benjamin Levy has been appointed Clinical Director, Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and Medical Director of the Thoracic Oncology Program in Washington, D.C. Prior to this appointment, Dr. Levy was Director of Thoracic Medical Oncology, Mount Sinai Health Systems and Associate Director, Cancer Clinical Trials Office, Mount…

Posted: February 2017 Keith Kerr received the 2016 IASLC Mary J. Matthews Pathology/ Translational Research Award, which is given to a scientist for lifetime scientific achievements in pathology/translational research of thoracic malignancies. Dr. Kerr is Honorary Professor of Pulmonary Pathology at Aberdeen University Medical School in Scotland, UK.

Posted: February 2017 Roy S. Herbst received the 2016 IASLC Paul A. Bunn, Jr. Scientific Award, which is given to an oncologist who has made outstanding scientific contributions to thoracic cancer research. Dr. Herbst is Ensign Professor of Medicine; Professor of Pharmacology; Chief of Medical Oncology; Director of the Thoracic Oncology Research Program; and Associate Director…

Posted: February 2017 Peter Hammerman has been appointed Global Head, Oncology Translational Research at Novartis Institutes for BioMedical Research (NIBR). Previous to this appointment, Dr. Hammerman was a Medical Oncologist and Physician Scientist at Dana-Farber Cancer Institute and Assistant Professor, Medicine, Harvard Medical School, Boston, US.

Thomas Stinchcombe has been recruited to the Duke Cancer Institute (DCI) where he will be promoted to Professor of Medicine in Medical Oncology. Tom will help lead the thoracic oncology group in the Solid Tumor Therapeutics Program and serve as co PI for the Alliance in the DCI. Prior to this, Dr. Stinchcombe was director of…

Charles B. Simone II has been appointed the Medical Director of the Maryland Proton Treatment Center (MPTC). Previous to this appointment, Dr. Simone was Associate Professor of Radiation Oncology at the Hospital of the University of Pennsylvania, Chief of the Thoracic Oncology Service, and Co-Director of the Penn Mesothelioma and Pleural Program at the University…

Tony Mok has been selected by the American Society of Clinical Oncology (ASCO) as a candidate for the 2017 ASCO Board of Directors. Professor Mok is a professor in the Department of Clinical Oncology at the Chinese University of Hong Kong in Prince of Wales Hospital in Hong Kong. Professor Mok is also the Immediate-Past President…

Richard B. Gaynor will retire as Senior Vice President, Global Development and Medical Affairs, Lilly Oncology as of January 2017. Prior to joining Lilly, Dr. Gaynor was a professor of medicine and microbiology at the University of Texas Southwestern Medical Center in Dallas, US. Editor note: See the interview with Dr. Gaynor on page 8.